#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16228	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2653	753.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1687	1687	C	1003	C	1002	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27440	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4096	835.0	0	.	n	.	0	T695C	SNP	695	695	T	1241	1241	C	992	C,A,G	989,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27440	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4096	835.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1883	1883	A	1165	A	1165	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27440	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4096	835.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2517	2517	C	988	C,G	987,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27440	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4096	835.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2591	2591	A	916	A	915	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27440	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4096	835.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3143	3143	C	979	C,T,A	977,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2346	folP	855	855	100.0	folP.l15.c4.ctg.1	1984	147.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1195	1197	AGC	248;250;249	A,T;G;C,A	246,1;250;248,1	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5612	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3892	179.6	1	SNP	p	S91F	1	.	.	271	273	TTC	881	883	TTC	206;208;210	T;T,G,C;C	206;206,1,1;210	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5612	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3892	179.6	1	SNP	p	G95N	0	.	.	283	285	GGC	893	895	GGC	226;225;221	G;G,T;C	226;224,1;221	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5612	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3892	179.6	1	SNP	p	D95G	1	.	.	283	285	GGC	893	895	GGC	226;225;221	G;G,T;C	226;224,1;221	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	27	2204	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1944	141.1	1	SNP	p	G45D	0	.	.	133	135	GGC	841	843	GGC	236;239;241	G,C,A;G;C	234,1,1;239;241	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1202	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1543	97.2	0	.	n	.	0	.206T	INS	206	206	T	865	865	T	251	T	248	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5450	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3397	199.8	1	SNP	p	D86N	0	.	.	256	258	GAC	826	828	GAC	228;228;229	G;A;C,G	228;228;227,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5450	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3397	199.8	1	SNP	p	R87W	0	.	.	259	261	CGT	829	831	CGT	227;229;233	C;G,C;T	227;227,1;232	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5450	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3397	199.8	1	SNP	p	S87R	1	.	.	259	261	CGT	829	831	CGT	227;229;233	C;G,C;T	227;227,1;232	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5450	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3397	199.8	1	SNP	p	R87I	0	.	.	259	261	CGT	829	831	CGT	227;229;233	C;G,C;T	227;227,1;232	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5450	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3397	199.8	1	SNP	p	S88P	0	.	.	262	264	TCC	832	834	TCC	233;234;237	T;C;C	232;233;236	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4534	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2970	189.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1673	1675	GGC	257;258;255	G;G;C,A	257;258;254,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4326	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2948	183.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1506	1508	GCA	255;252;254	G;C;A,C	255;252;253,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4326	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2948	183.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1509	1511	ATC	252;251;249	A;T;C	252;251;249	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4326	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2948	183.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1521	1523	GTG	252;249;249	G;T;G,T	252;249;248,1	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4326	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2948	183.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1521	1523	GTG	252;249;249	G;T;G,T	252;249;248,1	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4326	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2948	183.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2025	2027	ACC	244;244;248	A;C;C	244;244;248	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4326	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2948	183.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2079	2081	GCG	236;233;232	G;C;G,C	235;233;231,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4326	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2948	183.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2079	2081	GCG	236;233;232	G;C;G,C	235;233;231,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4326	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2948	183.1	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2202	2204	AGC	216;216;214	A;G;C	216;216;213	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4326	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2948	183.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2211	2213	GGC	220;223;223	G;G,T;C	219;222,1;222	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4326	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2948	183.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2229	2231	CCG	227;235;234	C,G;C;G	226,1;234;234	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5898	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3644	201.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1886	1888	CCG	254;253;250	C,A;C;G,A	252,2;253;248,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2408	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2370	126.5	0	.	p	.	0	S22G	NONSYN	64	66	AGC	674	676	GGC	177;175;175	G;G,T;C	177;174,1;175	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2408	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2370	126.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	856	856	C	155	C	155	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	356	porB1a	984	226	90.27	porB1a.l6.c17.ctg.2	767	16.3	0	.	p	.	0	V258L	NONSYN	772	774	GTA	133	135	TTA	29;35;35	T,A;T;A	28,1;35;35	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	356	porB1a	984	226	90.27	porB1a.l6.c17.ctg.2	767	16.3	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	178	180	CAT	66;66;66	C;A;T	66;66;66	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	356	porB1a	984	226	90.27	porB1a.l6.c17.ctg.2	767	16.3	0	.	p	.	0	D274S	NONSYN	820	822	GAT	181	183	AGT	66;66;66	A;G;T	66;66;66	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	356	porB1a	984	226	90.27	porB1a.l6.c17.ctg.2	767	16.3	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	190	192	TAC	66;66;66	T;A;C	66;66;66	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	356	porB1a	984	226	90.27	porB1a.l6.c17.ctg.2	767	16.3	0	.	p	.	0	R307A	NONSYN	919	921	AGA	280	282	GCA	2;3;3	G;C;A	2;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	356	porB1a	984	226	90.27	porB1a.l6.c17.ctg.2	767	16.3	0	.	p	.	0	T311A	NONSYN	931	933	ACA	292	294	GCA	4;4;4	G;C;A	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	356	porB1a	984	226	90.27	porB1a.l6.c17.ctg.2	767	16.3	0	.	p	.	0	E312D	NONSYN	934	936	GAA	295	297	GAC	5;5;5	G;A;C	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	356	porB1a	984	226	90.27	porB1a.l6.c17.ctg.2	767	16.3	0	.	p	.	0	F314I	NONSYN	940	942	TTC	301	303	ATC	5;5;5	A;T;C	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	356	porB1a	984	226	90.27	porB1a.l6.c17.ctg.2	767	16.3	0	.	p	.	0	A316S	NONSYN	946	948	GCG	307	309	TCG	5;5;5	T;C;G	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	356	porB1a	984	226	90.27	porB1a.l6.c17.ctg.2	767	16.3	0	.	p	.	0	V318A	NONSYN	952	954	GTC	313	315	GCC	5;5;5	G;C;C	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	356	porB1a	984	226	90.27	porB1a.l6.c17.ctg.2	767	16.3	0	.	p	.	0	G319S	NONSYN	955	957	GGC	316	318	AGC	5;5;5	A;G;C	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	356	porB1a	984	226	90.27	porB1a.l6.c17.ctg.2	767	16.3	0	.	p	.	0	G320A	NONSYN	958	960	GGT	319	321	GCC	5;5;5	G;C;C	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	356	porB1a	984	226	90.27	porB1a.l6.c17.ctg.2	767	16.3	0	.	p	.	0	G322V	NONSYN	964	966	GGT	325	327	GTT	6;6;6	G;T;T	6;6;6	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	356	porB1a	984	93	95.7	porB1a.l6.c17.ctg.3	167	65.9	0	.	p	.	0	M18T	NONSYN	52	54	ATG	126	128	ACG	73;71;71	A;C,G;G	73;70,1;71	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3158	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1860	210.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	568	570	GAA	292;291;292	G,A;A,T,C;A,G,C	291,1;287,3,1;290,1,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3158	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1860	210.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	856	858	GAT	269;264;267	G;A;T	268;264;267	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3158	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1860	210.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	979	981	TCA	275;278;283	T,A;C;A	274,1;278;283	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3158	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1860	210.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1108	1110	GTC	279;281;279	G;T,C;C	279;280,1;279	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3158	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1860	210.0	0	.	p	.	0	F222P	NONSYN	664	666	TTT	1120	1122	CCT	267;267;267	C,A;C,A;T,A	266,1;266,1;266,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3158	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1860	210.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1438	1440	GCA	269;270;270	G,T;C;A	268,1;270;270	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3158	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1860	210.0	1	SNP	p	G120K	1	.	.	358	360	AAG	814	816	AAG	272;273;273	A,C;A;G,A	270,2;273;272,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3158	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1860	210.0	1	SNP	p	A121D	1	.	.	361	363	GAC	817	819	GAC	271;275;277	G;A;C	271;275;277	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3158	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1860	210.0	1	SNP	p	D121N	0	.	.	361	363	GAC	817	819	GAC	271;275;277	G;A;C	271;275;277	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11154	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5361	259.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1692	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1437	146.5	1	SNP	p	V57M	1	.	.	169	171	ATG	719	721	ATG	300;303;300	A;T;G	300;303;300	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
